List of Moerae Matrix, Inc. patents

List of Moerae Matrix, Inc. patents

List of Zoetis patents

List of Arvinas patents

List of Browning Arms Company patents

List of companies in Bullish's investment portfolio

List of funding rounds for Akulaku

Patents where

Current Assignee

Name

is

‌

Moerae Matrix, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9890200 Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition	Patent 9890200 was granted and assigned to Moerae Matrix, Inc. on February, 2018 by the United States Patent and Trademark Office.	‌ Moerae Matrix, Inc.	‌ Moerae Matrix, Inc.		United States Patent and Trademark Office	9890200	February 13, 2018
	‌ US Patent 9642888 Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition	Patent 9642888 was granted and assigned to Moerae Matrix, Inc. on May, 2017 by the United States Patent and Trademark Office.		‌ Moerae Matrix, Inc.		United States Patent and Trademark Office	9642888	May 9, 2017
	‌ US Patent 10562947 Compositions and methods for preventing or treating diseases, conditions or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition	Patent 10562947 was granted and assigned to Moerae Matrix, Inc. on February, 2020 by the United States Patent and Trademark Office.	‌ Moerae Matrix, Inc.	‌ Moerae Matrix, Inc.		United States Patent and Trademark Office	10562947	February 18, 2020
	‌ US Patent 9034815 Polypeptide for treating or preventing adhesions	Patent 9034815 was granted and assigned to Moerae Matrix, Inc. on May, 2015 by the United States Patent and Trademark Office.		‌ Moerae Matrix, Inc.		United States Patent and Trademark Office	9034815	May 19, 2015
	‌ US Patent 10500249 Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition	Patent 10500249 was granted and assigned to Moerae Matrix, Inc. on December, 2019 by the United States Patent and Trademark Office.	‌ Moerae Matrix, Inc.	‌ Moerae Matrix, Inc.		United States Patent and Trademark Office	10500249	December 10, 2019
	‌ US Patent 10336788 Inhibition of cardiac fibrosis in myocardial infarction	Patent 10336788 was granted and assigned to Moerae Matrix, Inc. on July, 2019 by the United States Patent and Trademark Office.	‌ Moerae Matrix, Inc.	‌ Moerae Matrix, Inc.		United States Patent and Trademark Office	10336788	July 2, 2019
	‌ US Patent 9999655 Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with same	Patent 9999655 was granted and assigned to Moerae Matrix, Inc. on June, 2018 by the United States Patent and Trademark Office.	‌ Moerae Matrix, Inc.	‌ Moerae Matrix, Inc.		United States Patent and Trademark Office	9999655	June 19, 2018
	‌ US Patent 10087225 Formulation of MK2 inhibitor peptides	Patent 10087225 was granted and assigned to Moerae Matrix, Inc. on October, 2018 by the United States Patent and Trademark Office.	‌ Moerae Matrix, Inc.	‌ Moerae Matrix, Inc.		United States Patent and Trademark Office	10087225	October 2, 2018

8 results

0 selected

8 results

0 selected